Foley Represents PetMed Express in Acquisition of PetCareRx

06 April 2023 Media Contact: Jen Dilworth News

Foley & Lardner LLP represented PetMed Express, Inc. (NASDAQ: PETS), a leading nationwide pet pharmacy, in acquiring PetCareRx, Inc., a leading supplier of pet medications, food and supplies, for total consideration of approximately $36 million in an all-cash transaction.   

The acquisition will expand PETS’ overall addressable market from pet medication to a broader healthcare category leader. PetCareRx adds approximately 10,000 incremental food, diet, and wellness products to PETS’ current product offering. PETS believes it can expand its growth through a broader product catalog and differentiated services.

With the transaction’s closing, the consumer-facing PetCareRx e-commerce operation and the brand will continue to run separately. Customers will continue to enjoy the same service and e-commerce experience, supported by a more efficient distribution network and broader product selection.

The Foley deal team was led by Partners Curt Creely and Jonathan Witt and included Associates Caleb Erbert, Zach Ulewicz, and Kara Sweet, with additional support from Partner Nate Beaver.

About Foley & Lardner LLP

Foley & Lardner LLP is a preeminent law firm that stands at the nexus of the energy, health care and life sciences, innovative technology, and manufacturing sectors. We look beyond the law to focus on the constantly evolving demands facing our clients and act as trusted business advisors to deliver creative, practical, and effective solutions. Our 1,100 lawyers across 25 offices worldwide partner on the full range of engagements from corporate counsel to IP work and litigation support, providing our clients with a one-team solution to all their needs. For nearly two centuries, Foley has maintained its commitment to the highest level of innovative legal services and to the stewardship of our people, firm, clients, and the communities we serve.